COVID-19? Let me see your hands.
David Bernal-BelloCelia Lara-MontesBeatriz Jaenes-BarriosPublished in: The journal of the Royal College of Physicians of Edinburgh (2023)
During the first wave of the coronavirus disease 2019 pandemic, a patient with anti-synthetase syndrome (ASS) was misdiagnosed as having bilateral severe acute respiratory syndrome coronavirus 2 pneumonia on admission. A comprehensive clinical evaluation would have led to the correct diagnosis earlier, as he had some data consistent with ASS on both physical examination and laboratory tests that were initially overlooked. In addition, a malignant lesion in the colon was found on screening for underlying malignancy. In this context, ASS has been considered a low-risk subgroup for cancer among idiopathic inflammatory myopathies. However, this should be interpreted cautiously and should not lead to neglect of adequate cancer screening adjusted for age, sex and other potential risk factors.
Keyphrases
- coronavirus disease
- respiratory syndrome coronavirus
- sars cov
- papillary thyroid
- clinical evaluation
- risk factors
- case report
- squamous cell
- emergency department
- physical activity
- randomized controlled trial
- electronic health record
- oxidative stress
- clinical trial
- big data
- machine learning
- deep learning
- young adults
- human health
- phase iii
- extracorporeal membrane oxygenation
- double blind
- mechanical ventilation